Call for Abstracts
1.Important Dates
| Call for Abstracts Open Date |
April 8, 2024 (10:00 JST) |
|---|---|
| Abstract Submission Deadline |
April 30, 2024 (17:00 JST) |
| Acceptance notification | Around mid-May 2024 |
| Registration Deadline for Presenters |
May 31, 2024 (17:00 JST) |
2. General Rules for Abstract Submission
- Applicants for English Presentations will not be required to be a member of Japanese Society for Palliative Medicine(JSPM) or Japan Psycho - Oncology Society(JPOS)
- Please do not submit abstracts that have already been published or presented.
- The session conveners reserve the right to reject submitted abstracts that are poorly written, do not follow the submission guidelines, and/or are outside the scope of the conference.
- Notification regarding acceptance or rejection of abstracts will be sent to the presenting author around mid-May 2024 by email.
3. Abstract Preparation Guidelines
1) Abstract Body
| Abstract Formats by Report Type |
Abstracts should use the following structured format: [Background/aims] [Methods] [Results] [Conclusions] |
|
|---|---|---|
| Number of words | Title | The total number of words is limited to 20 words. |
| Author | The maximum number of presenters is up to 11 persons per abstract, including first author and co-authors. | |
| Affiliation | The maximum affiliated facility is up to six facilities. | |
| Body | The total number of characters in the abstract body is limited to 250 words (including spaces). Registration is not possible if the number of characters exceeds this limit. | |
2) Number of the Abstract
- No limit is set to the number of abstracts that an author may submit.
- If you live overseas and cannot visit the site, you may only present an e-poster.
3) Other
- All abstracts must be written in clear English and submitted as poster presentations.
- The authors should ensure that the text does not contain typos or grammatical errors.
- Proprietary names of drugs are not allowed – the generic names must be used.
4. Disclosure of Conflict of Interest (COI) (Mandatory):
1) Conflict of Interest: A potential conflict of interest exists when involvement is present between the speaker/presenter with any for-profit commercial form or organization (FPC). This includes, but is not limited to, one or more of the following: you have 10% or more of stock of an FPC; you have received more than 1 million yen as research expenses in total related to clinical medicine studies; or you are a lecturer working for an FPC, from which income is derived, an officer, a board member, an owner, or an employee of an FPC.
2) When submitting your abstract, please reply to the questions regarding the COI.
3) All authors will be required to disclose the COI somewhere in their poster presentation.
5. How to register
1) Abstract Registration
Please use the prescribed form and send it to the Management Office (
) by e-mail. After the secretariat confirms the receipt of the form, an e-mail will be sent to you. If you do not receive a confirmation e-mail within 5 business days after sending the e-mail, please contact the Management Office.
Please click here to view the categories.
2) Please contact the convention secretariat by e-mail (
) by 17:00 on Friday, April 30, 2024.
6. Acceptance/Rejection Notification
*All abstracts will be reviewed in the same manner. Abstract acceptance is determined by the Congress Chairperson 2024 based on the reviews from the Abstract Review Committee commissioned by the Congress Chairperson.
*The first author will be notified of the decision of Acceptance/Rejection by email from the Abstract Division at
around mid-May 2024. Your presentation style and date/time will also be notified.